Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC

Published:2014-04-07 Issue:11 Volume:28 Page:2213-2221
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Busfield S J,Biondo M,Wong M,Ramshaw H S,Lee E M,Ghosh S,Braley H,Panousis C,Roberts A W,He S Z,Thomas D,Fabri L,Vairo G,Lock R B,Lopez A F,Nash A D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014128.pdf

Reference48 articles.

1. Roboz GJ . Current treatment of acute myeloid leukemia. Curr Opin Oncol 2012; 24: 711–719.

2. Bonnet D, Dick JE . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730–737.

3. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645–648.

4. Hope KJ, Jin L, Dick JE . Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004; 5: 738–743.

5. Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001; 98: 2301–2307.

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-3: key orchestrator of inflammation;Frontiers in Immunology;2024-06-13

2. EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia;Cell Communication and Signaling;2024-04-02

3. Stem Cell Transplantation and Cellular Immunotherapies for Pediatric AML;Pediatric Oncology;2024

4. Unlocking the Power of Immune Microenvironment in AML Therapy: Current Insight and Future Prospects;Interdisciplinary Cancer Research;2024

5. Blastic Plasmacytoid Dendritic Cell Neoplasm;Advances in Molecular Pathology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3